Pembrolizumab-induced reactivation of bullous pemphigoid

Int J Dermatol. 2021 Jun;60(6):757-758. doi: 10.1111/ijd.15366. Epub 2020 Dec 8.
No abstract available

Keywords: PD-1; PD-L1; adverse effect; bullous pemphigoid; checkpoint inhibitors; immunotherapy; lung cancer; pembrolizumab; vesiculobullous.

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Nivolumab
  • Pemphigoid, Bullous* / chemically induced

Substances

  • Antibodies, Monoclonal, Humanized
  • Nivolumab
  • pembrolizumab